Bone Metastases
📧 Sign up to get email alerts when something new happens for Bone Metastases.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-19FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Zoledronic Acid from Hikma Pharmaceuticals USA Inc., resulting in a supplemental approval fo…
-
FDA approval · 2015-10-19FDA Approved: SODIUM FLUORIDE F 18 — Original Application (3D Imaging Drug Design and Development LLC)
The FDA approved the original application for Sodium Fluoride F-18, an imaging agent for PET bone imaging to help detect bone abnormalities …
-
FDA approval · 2015-10-19FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)
FDA approves a supplemental application for zoledronic acid from BPI Labs LLC under ANDA 202930. This action supports continued availability…
-
FDA label_change · 2015-10-08FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)
FDA supplemental application for Zoledronic Acid submitted by Sagent Pharmaceuticals to modify the drug's labeling.
-
FDA approval · 2015-09-28FDA Approved: SODIUM FLUORIDE F 18 — Original Application (PETNET Solutions, Inc.)
FDA approved Sodium Fluoride F-18 for PET imaging through an Original Application filed by PETNET Solutions, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer [Phase 4]
Phase 4 study evaluating the short-term efficacy of intravenous ibandronate (Bondronat) in participants with metastatic bone pain due to bre…
-
FDA approval · 2015-09-10FDA Approved: KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Cardinal Health 414, LLC)
FDA approved a supplemental application for the Kit for the Preparation of Technetium Tc-99m Medronate, enabling continued use in preparing …
-
FDA approval · 2015-08-18FDA Approved: SODIUM FLUORIDE F 18 — Original Application (SOFIE Co.)
FDA approved Sodium Fluoride F-18 from SOFIE Co. via an Original Application for use as a radiopharmaceutical in PET bone imaging to evaluat…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect [Phase 2, Phase 3]
The update reports on the duration of bone turnover suppression achieved with zoledronic acid in patients with metastatic breast cancer invo…
-
FDA approval · 2015-05-27FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)
FDA approved a supplemental application for zoledronic acid from BPI Labs LLC under an ANDA.
-
FDA approval · 2015-05-26FDA Approved: KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for the kit used to prepare technetium-99m medronate for bone imaging, enabling regulatory approval …
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC
This completed clinical trial reports on the duration of suppression of bone turnover after treatment with zoledronic acid in men with metas…
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) [Phase 1]
Phase 1 trial of MK0429 in prostate cancer with metastatic bone disease has completed.
-
FDA approval · 2015-04-09FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Dr.Reddy's Laboratories Ltd)
FDA approved a supplemental application for zoledronic acid from Dr. Reddy's Laboratories Ltd (ANDA 091363), granting regulatory approval of…
-
FDA approval · 2015-02-27FDA Approved: SODIUM FLUORIDE F 18 — Original Application (Precision Nuclear LLC)
The FDA approved the original application for Sodium Fluoride F-18, a PET radiotracer from Precision Nuclear LLC used for diagnostic bone im…
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases [NA]
A completed clinical trial compared single- versus multi-fraction radiotherapy for previously irradiated painful bone metastases; results po…
-
CLINICAL_TRIALS research · 2015-02-09Clinical Trial Update: Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases [Phase 1, Phase 2]
The document describes an ongoing Phase 1/2 clinical trial comparing single-fraction intensity-modulated radiotherapy (IMRT) to standard ext…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases [Phase 1]
A Phase 1 trial evaluating hydroxychloroquine in adults with solid tumors undergoing radiation therapy for bone metastases was terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases
A completed clinical trial update examining risk factors for skeletal-related events in breast cancer patients with bone metastases treated …
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology [NA]
Clinical trial update on aspirin and compression devices for venous thromboembolism prophylaxis in orthopaedic oncology completed, with resu…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer [EARLY_Phase 1]
Early-phase trial evaluating whole-body F-18 sodium fluoride PET/CT and whole-body MRI to detect bone metastases in prostate cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease [Phase 2]
Update on a Phase 2 trial of BAY88-8223 (Alpharadin) in breast cancer patients with bone-dominant disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: S0916, MLN1202 in Treating Patients With Bone Metastases [Phase 2]
Phase 2 trial update for S0916 and MLN1202 in patients with bone metastases has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Phase 3]
A Phase 3 clinical trial comparing denosumab with zoledronic acid for treating bone metastases in advanced cancer or multiple myeloma has co…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer [Phase 3]
Phase 3 trial comparing denosumab to zoledronic acid for bone metastases in men with hormone-refractory prostate cancer completed with resul…